Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group

Cancer-related cognitive impairment (CRCI) is commonly experienced by individuals with non-central nervous system cancers throughout the disease and treatment trajectory. CRCI can have a substantial impact on the functional ability and quality of life of patients and their families. To mitigate the...

Full description

Saved in:
Bibliographic Details
Published inSupportive care in cancer Vol. 29; no. 6; pp. 2821 - 2840
Main Authors Mayo, Samantha J., Lustberg, Maryam, M. Dhillon, Haryana, Nakamura, Zev M., Allen, Deborah H., Von Ah, Diane, C. Janelsins, Michelle, Chan, Alexandre, Olson, Karin, Tan, Chia Jie, Toh, Yi Long, Oh, Jeong, Grech, Lisa, Cheung, Yin Ting, Subbiah, Ishwaria Mohan, Petranovic, Duska, D’Olimpio, James, Gobbo, Margherita, Koeppen, Susanne, Loprinzi, Charles L., Pang, Linda, Shinde, Shivani, Ntukidem, Olanipekun, Peters, Katherine B.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.06.2021
Springer
Springer Nature B.V
Subjects
Brain cancer
Cancer
Cancer therapies
Care and treatment
Central nervous system
Chemotherapy
Cognitive ability
Cognitive Dysfunction - etiology
Complications and side effects
Humans
Medical diagnosis
Medical research
Medicine
Medicine & Public Health
Medicine, Experimental
Neoplasms - complications
Nervous system
Nursing
Nursing Research
Oncology
Pain Medicine
Patient education
Rehabilitation Medicine
Review Article
Cancer-related cognitive impairment
Chemotherapy-related cognitive impairment
Cognition
CRCI
Cognitive functioning
Cancer
Online AccessGet full text

Cover

More Information
Summary:Cancer-related cognitive impairment (CRCI) is commonly experienced by individuals with non-central nervous system cancers throughout the disease and treatment trajectory. CRCI can have a substantial impact on the functional ability and quality of life of patients and their families. To mitigate the impact, oncology providers must know how to identify, assess, and educate patients and caregivers. The objective of this review is to provide oncology clinicians with an overview of CRCI in the context of adults with non-central nervous system cancers, with a particular focus on current approaches in its identification, assessment, and management.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0941-4355
1433-7339
1433-7339
DOI:10.1007/s00520-020-05860-9